LexDanaLexDanabeta
Inventor

Brett PRIGARO

Inventor
US

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes14%
PatentTitleYear
11,964,988Fused heterocyclic compounds as RET kinase inhibitors202411,603,374Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors202311,524,963Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to ARRAY BIOPHARMA INC (3)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARRAY BIOPHARMA INC32022–2024
Locations
LocationPatentsSpan
US32022–2024